Composition
Imipenem and Cilastatin for Injection IP
Interested in this product?
Contact us for export pricing, bulk orders, and regulatory documentation.
Request QuoteProduct Overview
Imipiberg combines Imipenem with Cilastatin, which inhibits renal dehydropeptidase to prevent Imipenem breakdown, maintaining effective drug levels.
Indication
Serious polymicrobial infections, nosocomial pneumonia, complicated intra-abdominal infections, and febrile neutropenia.
Packaging
Single vial pack
Storage
Store below 25°C, protected from light. Use reconstituted solution as directed.
Export Ready
Available for export with full regulatory documentation, COA, and dossier support for international registration.
Disclaimer: This product information is intended for healthcare professionals and authorized distributors only. It is not intended as medical advice. Please refer to the full prescribing information for complete details. Regulatory approvals may vary by country.